FDA clears Adicet Bio IND application for prostate cancer therapy
Go back to FDA clears Adicet Bio IND application for prostate cancer therapy| Aceto Corp (NASDAQ: ACET) | Delayed: 9.69 +0.10 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.59 | 52 Week High | $28.54 | |||
| Open | $9.61 | 52 Week Low | $15.69 | |||
| Day High | $9.97 | P/E | 8.73 | |||
| Day Low | $9.38 | EPS | $1.11 | |||
| Volume | 39,928 | |||||

